These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Terfenadine therapy: can we justify the risks? Rangno R CMAJ; 1997 Jul; 157(1):37-8. PubMed ID: 9220940 [No Abstract] [Full Text] [Related]
13. [Acute cytolytic hepatitis during administration of oxatomide]. De Parades V; Roulot D; Neyrolles N; Rautureau J; Coste T Gastroenterol Clin Biol; 1994; 18(3):294. PubMed ID: 7926451 [No Abstract] [Full Text] [Related]
14. FDA announces plan to halt marketing of terfenadine. Am J Health Syst Pharm; 1997 Feb; 54(4):342. PubMed ID: 9043551 [No Abstract] [Full Text] [Related]
15. Terfenadine and SSRIs. Tafler G CMAJ; 1997 Oct; 157(8):1019. PubMed ID: 9347771 [No Abstract] [Full Text] [Related]
16. Dangers of non-sedating antihistamines. Clark S Lancet; 1997 May; 349(9061):1268. PubMed ID: 9142059 [No Abstract] [Full Text] [Related]